Dr. Saba is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
7777 Hennessy Blvd
Ste 7000
Baton Rouge, LA 70808Phone+1 225-757-0343Fax+1 225-757-8354
Education & Training
- Tulane University School of MedicineClass of 2005
Certifications & Licensure
- LA State Medical License 2012 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Expanded Access to Convalescent Plasma to Treat and Prevent Pulmonary Complications Associated With COVID-19
- realMIND: Observational Study on Safety and Effectiveness of Tafasitamab in Combination With Lenalidomide in Patients With Relapsed or Refractory DLBCL Start of enrollment: 2021 Sep 20
Roles: Contact
Publications & Presentations
PubMed
- Programmed death-ligand 1 expression in patients with primary or secondary myelofibrosis.Moayed Ibrahim, Catherine Murphree, Kirtesh Patel, Matthew Mastrodomenico, Nakhle S Saba
Cancer Reports. 2024-09-01 - 1 citationsProfiling the activity of the para-caspase MALT1 in B-cell acute lymphoblastic leukemia for potential targeted therapeutic application.Firas M Safa, Terri Rasmussen, Lorena Fontan, Min Xia, Ari Melnick
Haematologica. 2024-05-01 - 8 citationsPhase I Study of Acalabrutinib Plus Danvatirsen (AZD9150) in Relapsed/Refractory Diffuse Large B-Cell Lymphoma Including Circulating Tumor DNA Biomarker Assessment.Mark Roschewski, Manish R Patel, Patrick M Reagan, Nakhle S Saba, Graham P Collins
Clinical Cancer Research. 2023-09-01
Press Mentions
- New Orleans Doctors, Medical Researchers Adapt to FDA Plasma Therapy Authorization, but Questions LingerSeptember 15th, 2020
- These 4 New Louisiana Laws Aim to Help Cancer PatientsJuly 12th, 2023
- Tulane Stem Cell Transplant Program to Begin Using CAR-T Cell TherapyJuly 30th, 2023
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: